Pantoprazole versus one-week Helicobacter pylori eradication therapy for the prevention of acute NSAID-related gastroduodenal damage in elderly subjects

Alimentary Pharmacology and Therapeutics

Volumn 14, Issue 8, 2000, Pages 1077-1082

  Pilotto, A ^a,c   Di Mario, F ^b   Franceschi, M ^a   Leandro, G ^b   Battaglia, G ^b   Germana B ^b   Marin, R ^b   Valerio, G ^a  

^a Digestive Pathophysiology Center   (Italy)

^b Department of Gastroenterology ^*  (Italy)

^c SAN BORTOLO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CLARITHROMYCIN; NONSTEROID ANTIINFLAMMATORY AGENT; PANTOPRAZOLE; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; DRUG EFFICACY; DUODENUM INJURY; ERADICATION THERAPY; FEMALE; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STOMACH INJURY;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; AGE FACTORS; AGED; AGING; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTI-ULCER AGENTS; BENZIMIDAZOLES; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; DUODENAL DISEASES; ENDOSCOPY; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PENICILLINS; PROTON PUMPS; STOMACH DISEASES; SULFOXIDES;

EID: 0033864302     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2000.00804.x     Document Type: Article

References (28)

1. 1 Pilotto A. Helicobacter pylori infection in the elderly. Clin Geriatrics 1996; 4: 53-70.
2. 2 Kemppainen H, Raiha I, Kujari H, Sourander L. Characteristics of Helicobacter pylori-negative and -positive peptic ulcer disease. Age Ageing 1998; 27: 427-31.
3. 3 Pilotto A, Franceschi M, Leandro G, Di Mario F, Valerio G. The effect of Helicobacter pylori infection on NSAID-related gastroduodenal damage in the elderly. Eur J Gastroenterol Hepatol 1997; 9: 951-6.
4. 4 Hawkey CJ. Personal review: Helicobacter pylori, NSAIDs and cognitive dissonance. Aliment Pharmacol Ther 1999; 13: 695-702.
5. 5 Bretagne JF, Quina MG. Helicobacter pylori and non-steroidal anti-inflammatory drugs. Curr Opin Gastroenterol 1999; 15(Suppl. 1): S61-5.
6. 6 Graham DY, White RH, Moreland LW, et al. Duodenal and gastric ulcer prevention with misoprostol in arthritic patients taking NSAIDs. Ann Intern Med 1993; 119: 257-62.
7. 7 Taha AS, Hudson N, Hawkey CJ, et al. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs. N Engl J Med 1996; 334: 1435-9.
8. 8 Yeomans ND, Tulassay Z, Juhasz L, et al. For the ASTRONAUT Study Group. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. N Engl J Med 1998; 338: 719-26.
9. 9 Hawkey CJ, Karrasch JA, Szczepanski L, et al. For the OMNIUM Study Group. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. N Engl J Med 1998; 338: 727-34.
10. 10 Chan FKL, Sung JJY, Chung SCS, et al. Randomised trial of eradication of Helicobacter pylori before non-steroidal antiinflammatory drug therapy to prevent peptic ulcers. Lancet 1997; 350: 975-9.
11. 11 Hawkey CJ, Tulassay Z, Szczepanski L, et al. Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Lancet 1998; 352: 1016-21.
12. 12 Aadland E, Fausa O, Vatn M. Protection by misoprostol against naproxen-induced gastric mucosal damage. Am J Med 1987; 83(Suppl. 1): 37-40.
13. 13 Bianchi Porro G, Parente F, Imbesi V, Montrone F, Caruso I. Role of Helicobacter pylori infection in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users. Response to omeprazole dual therapy. Gut 1997; 39: 22-6.
14. 14 Chan FKL, Sung JY, Suen R, et al. Eradication of H. pylori versus maintenance acid suppression to prevent recurrent ulcer haemorrhage in high risk NSAID users. A prospective randomised study. Gastroenterology 1998; 114: A87(Abstract).
15. 15 Kemppainen H, Raiha I, Sourander L. Clinical presentation of bleeding peptic ulcer in the elderly. Aging Clin Exp Res 1996; 42: 184-8.
16. 16 Pilotto A, Leandro G, Di Mario F, Franceschi M, Bozzola L, Valerio G. Role of Helicobacter pylori infection on upper gastrointestinal bleeding in the elderly. A case-control study. Dig Dis Sci 1997; 42: 586-91.
17. 17 Ekstrom P, Carling S, Wetterhus S, et al. Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non steroidal anti-inflammatory drugs. Scand J Gastroenterol 1996; 31: 753-8.
18. 18 Bianchi Porro G, Lazzaroni M, Petrillo M, Manzionna G, Montrone F, Caruso I. Prevention of gastrodudoenal damage with omeprazole in patients receiving continuous NSAIDs treatment. A double blind placebo controlled study. Ital J Gastroenterol Hepatol 1998; 30: 43-7.
19. 19 Cullen D, Bardhan KD, Eisner M, et al. Primary gastroduodenal prophylaxis with omeprazole for non-steroidal antiinflammatory drug users. Aliment Pharmacol Ther 1998; 12: 135-40.
20. 20 Bianchi Porro G, Imbesi V, Lazzaroni M, Montrone F, Santagada T. Pantoprazole versus placebo in prevention of NSAID-induced ulcers. Gastroenterology 1998; 114(Suppl.): G-806.
21. 21 Simon B, Muller P. Pantoprazole protects against aspirin-induced damage in the upper gastro-intestinal tract. Gut 41 (Suppl, 1997; 3): A198(Abstract).
22. 22 Zech K, Steinijans VW, Huber R, Kolassa N, Radtke HW. Pharmacokinetics and drug interactions: relevant factors for the choice of a drug. Int J Clin Pharmacol Ther 1996; 34(Suppl. 1): S3-S6.
23. 23 Bliesath H, Huber R, Steinijans VW, Koch HJ, Wurst W, Mascher H. Lack of pharmacokinetic interaction between pantoprazole and diclofenac. Int J Clin Pharmacol Ther 1996; 34: 152-6.
24. 24 Pilotto A, Franceschi M, Leandro G, et al. Efficacy of 7 day lansoprazole-based triple therapy for Helicobacter pylori infection in elderly patients. J Gastroenterol Hepatol 1999; 14: 468-75.
25. 25 Pilotto A, Leandro G, Franceschi M, et al. The effect of antibiotic resistance on the outcome of three 1-week triple therapies against Helicobacter pylori. Aliment Pharmacol Ther 1999; 13: 667-73.
26. 26 Williams MP, Sercombe JC, Lawson AJ, Slater E, Owen RJ, Pounder RE. The effect of omeprazole dosing on the isolation of Helicobacter pylori from gastric aspirates. Aliment Pharmacol Ther 1999; 13: 1161-9.
27. 27 Vigneri S, Termini R, Di Mario F, Scialabba A, Pisciotta G. Omeprazole therapy modifies the gastric localization of Helicobacter pylori. Am J Gastroenterol 1991; 86: 1276.
28. 28 Marshall B. NSAIDs and Helicobacter pylori: therapeutic options. Lancet 1998; 352: 1001-3.